Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis

Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis

COVID-19 patients are at high risk for both capillary micro thrombi and large vessel thrombosis. Anticoagulant administration in COVID-19 patients, especially in ICU setting, is recommended by some researchers. However, clinical guidelines don't yet recommend anticoagulation therapies in therap...

Full description

Bibliographic Details
Main Authors: Amir Javid, Reza Kazemi, Mehdi Dehghani, Hossein Bahrami Samani
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:Urology Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2214442021000085
id doaj-97c0ce138f3043e397812c17ef3cf5cf
record_format Article
spelling doaj-97c0ce138f3043e397812c17ef3cf5cf2021-03-11T04:24:59ZengElsevierUrology Case Reports2214-44202021-05-0136101568Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxisAmir Javid0Reza Kazemi1Mehdi Dehghani2Hossein Bahrami Samani3Department of Urology, School of Medicine, Khorshid Hospital, Isfahan University of Medical Sciences, IranDepartment of Urology, School of Medicine ,Al-Zahra Hospital, Khorshid Hospital , Isfahan University of Medical Sciences, Iran.; Department of Urology, School of Medicine, Al-Zahra Hospital, Khorshid Hospital, Isfahan University of Medical Sciences, IranDepartment of Urology, School of Medicine, Al-Zahra Hospital, Isfahan University of Medical Sciences, IranDepartment of Urology, School of Medicine, Al-Zahra Hospital, Isfahan University of Medical Sciences, IranCOVID-19 patients are at high risk for both capillary micro thrombi and large vessel thrombosis. Anticoagulant administration in COVID-19 patients, especially in ICU setting, is recommended by some researchers. However, clinical guidelines don't yet recommend anticoagulation therapies in therapeutic doses in these patients.In this article, we try to introduce a less known complication of heparin application in COVID-19 patients. Retroperitoneal hemorrhage when involves the psoas muscle might be deadly because of the large volume of bleeding before causing any significant alarm. It is very important to be careful in diagnosing and managing this complication.http://www.sciencedirect.com/science/article/pii/S2214442021000085
collection DOAJ
language English
format Article
sources DOAJ
author Amir Javid
Reza Kazemi
Mehdi Dehghani
Hossein Bahrami Samani
spellingShingle Amir Javid
Reza Kazemi
Mehdi Dehghani
Hossein Bahrami Samani
Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
Urology Case Reports
author_facet Amir Javid
Reza Kazemi
Mehdi Dehghani
Hossein Bahrami Samani
author_sort Amir Javid
title Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
title_short Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
title_full Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
title_fullStr Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
title_full_unstemmed Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
title_sort catastrophic retroperitoneal hemorrhage in covid-19 patients under anticoagulant prophylaxis
publisher Elsevier
series Urology Case Reports
issn 2214-4420
publishDate 2021-05-01
description COVID-19 patients are at high risk for both capillary micro thrombi and large vessel thrombosis. Anticoagulant administration in COVID-19 patients, especially in ICU setting, is recommended by some researchers. However, clinical guidelines don't yet recommend anticoagulation therapies in therapeutic doses in these patients.In this article, we try to introduce a less known complication of heparin application in COVID-19 patients. Retroperitoneal hemorrhage when involves the psoas muscle might be deadly because of the large volume of bleeding before causing any significant alarm. It is very important to be careful in diagnosing and managing this complication.
url http://www.sciencedirect.com/science/article/pii/S2214442021000085
work_keys_str_mv AT amirjavid catastrophicretroperitonealhemorrhageincovid19patientsunderanticoagulantprophylaxis
AT rezakazemi catastrophicretroperitonealhemorrhageincovid19patientsunderanticoagulantprophylaxis
AT mehdidehghani catastrophicretroperitonealhemorrhageincovid19patientsunderanticoagulantprophylaxis
AT hosseinbahramisamani catastrophicretroperitonealhemorrhageincovid19patientsunderanticoagulantprophylaxis
_version_ 1724226044698820608

Similar Items